Use of erythropoiesis-stimulating agents in children with chronic kidney disease: a systematic review

BACKGROUND: Erythropoiesis-stimulating agents (ESAs) revolutionized the management of anaemia in chronic kidney disease (CKD) when introduced in the late 1980s. A range of ESA types, preparations and administration modalities now exist, with newer agents requiring less frequent administration. Altho...

Descripción completa

Detalles Bibliográficos
Autores principales: Bruce, Gordon, Schulga, Peter, Reynolds, Ben C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
CKJ Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9308099/
https://www.ncbi.nlm.nih.gov/pubmed/35892014
http://dx.doi.org/10.1093/ckj/sfac058

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9308099/
https://www.ncbi.nlm.nih.gov/pubmed/35892014
http://dx.doi.org/10.1093/ckj/sfac058

Ejemplares similares